Literature DB >> 19576653

EASL clinical practice guidelines.

Jozef Holomán, Jozef Glasa.   

Abstract

Mesh：

Year:  2009        PMID： 19576653     DOI： 10.1016/j.jhep.2009.05.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  7 in total

1.  Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria.

Authors:  Claudia Hawkins; Oche Agbaji; Placid Ugoagwu; Chloe L Thio; Muazu M Auwal; Charles Ani; Chinedum Okafo; Erika Wallender; Robert L Murphy
Journal:  Clin Infect Dis       Date:  2013-09-06       Impact factor: 9.079

2.  High dose lamivudine in HBV-related cirrhotic patients with unsatisfactory response after adefovir add-on.

Authors:  Marco Montagnani; Marina Giandinoto; Andrea Lisotti; Silvia Galli; Francesco Azzaroli; Federica Buonfiglioli; Laura Turco; Rita Aldini; Giuseppe Mazzella
Journal:  Dig Dis Sci       Date:  2011-09-01       Impact factor: 3.199

3.  Efficacy of entecavir and adefovir combination therapy for patients with lamivudine- and entecavir-resistant chronic hepatitis B.

Authors:  Jung Won Jeon; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Jae Myung Cha; Jae Jun Park; Jun Uk Lim; Kyuseong Lim; Sunyong Kim
Journal:  Dig Dis Sci       Date:  2011-12-02       Impact factor: 3.199

4.  Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B.

Authors:  Mi Sung Park; Beom Kyung Kim; Kyung Sik Kim; Ja Kyung Kim; Seung Up Kim; Jun Yong Park; Do Young Kim; Oidov Baartarkhuu; Kwang Hyub Han; Chae Yoon Chon; Sang Hoon Ahn
Journal:  Clin Mol Hepatol       Date:  2013-03-25

5.  The efficacy of adefovir plus entecavir combination therapy in patients with chronic hepatitis B refractory to both lamivudine and adefovir.

Authors:  Yuri Cho; Dong Hyeon Lee; Kwang Hyun Chung; Eunhyo Jin; Jeong-Hoon Lee; Eun Ju Cho; Su Jong Yu; Jin Wook Kim; Sook Hyang Jeong; Jung-Hwan Yoon; Hyo-Suk Lee; Chung Yong Kim; Yoon Jun Kim
Journal:  Dig Dis Sci       Date:  2012-11-23       Impact factor: 3.199

6.  Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B.

Authors:  Chung Hwan Jun; Hyoung Ju Hong; Min Woo Chung; Seon Young Park; Sung Bum Cho; Chang Hwan Park; Young Eun Joo; Hyun Soo Kim; Sung Kyu Choi; Jong Sun Rew
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

7.  Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review.

Authors:  Xuan Li; Min Liao; Qiong Pan; Qiaoling Xie; Hong Yang; Ying Peng; Qiao Li; Jiaquan Qu; Jin Chai
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-09       Impact factor: 2.586
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.